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Background. Intermittent screening and treatment in pregnancy (ISTp) is a potential strategy for the control of malaria during preg-
nancy. However, the frequency and consequences of malaria infections missed by a rapid diagnostic test (RDT) for malaria are a concern.
Methods. Primigravidae and secundigravidae who participated in the ISTp arm of a noninferiority trial in 4 West African countries
were screened with an HRP2/pLDH RDT on enrollment and, in Ghana, at subsequent antenatal clinic (ANC) visits. Blood samples were
examined subsequently by microscopy and by a polymerase chain reaction (PCR) assay.
Results. The sensitivity of the RDT to detect peripheral blood infections conﬁrmed by microscopy and/or PCR at enrollment ranged
from 91% (95% conﬁdence interval [CI], 88%, 94%) in Burkina Faso to 59% (95% CI, 48%, 70% in The Gambia. In Ghana, RDT sensitivity
was 89% (95% CI, 85%, 92%), 83% (95% CI, 76%, 90%) and 77% (95% CI, 67%, 86%) at enrollment, second and third ANC visits re-
spectively but only 49% (95% CI, 31%, 66%) at delivery. Screening at enrollment detected 56% of all infections detected throughout preg-
nancy. Seventy-ﬁve RDT negative PCR or microscopy positive infections were detected in 540 women; these were not associated with
maternal anemia, placental malaria, or low birth weight.
Conclusions. The sensitivity of an RDT to detect malaria in primigravidae and secundigravidae was high at enrollment in 3 of 4
countries and, in Ghana, at subsequent ANC visits. In Ghana, RDT negative malaria infections were not associated with adverse birth
outcomes but missed infections were uncommon.
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Intermittent preventive treatment of malaria in pregnancy with
sulfadoxine-pyrimethamine (IPTp-SP) reduces the incidence of
maternal anemia, low birth weight, and neonatal mortality
[1, 2]. The World Health Organization now recommends ad-
ministration of IPTp-SP at each antenatal clinic (ANC) visit
after the ﬁrst trimester [3]. However, in parts of eastern and
southern Africa Plasmodium falciparum has become highly re-
sistant to SP and IPTp-SP is losing some of its impact [4–11].
Currently, there is no recommended drug to replace SP for
IPTp, as both meﬂoquine and azithromycin/chloroquine were
not well tolerated when evaluated for this purpose [12, 13].
However, dihydro-artemisinin /piperaquine shows promise as
an alternative to SP for IPTp [14].
Intermittent screening and treatment (ISTp) is being eva-
luated as a potential alternative to IPTp-SP that might be
applicable in areas where P. falciparum has developed a high
level of resistance to SP, or where malaria transmission has
fallen to a level at which very few women will beneﬁt from re-
ceiving IPTp. ISTp involves screening pregnant women at
each ANC visit with a rapid diagnostic test for malaria
(RDT) and treating those who test positive. A pilot study of
ISTp in Ghana using SP or artesunate-amodiaquine [15],
and a multicenter trial using artemether-lumefantrine (AL)
conducted in 4 countries in West Africa where P. falciparum
is still sensitive to SP [16], have shown that ISTp was noninfe-
rior to IPTp-SP in preventing maternal anemia, low birth
weight, and placental malaria. However, RDTs used in ISTp
may miss some low density infections, which would not be
treated, and these missed infections could have an adverse im-
pact on the outcome of pregnancy. Therefore, we have inves-
tigated the performance of an RDT in pregnant women given
ISTp during a recent multicenter trial [16], characterized the
factors associated with infections missed by an RDT, and
investigated the consequences of these infections on the out-
come of pregnancy.
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METHODS
Blood samples were obtained during a large multicenter trial of
ISTp vs IPTp-SP conducted in 4 countries in West Africa [16].
Only women randomized to the ISTp-AL group are included in
the analyses described in this article. The key features of this
trial are summarized in Supplementary Table 1.
Study Procedures
Women who consented to join the trial were randomized indi-
vidually to 1 of 2 study arms (IPTp-SP or ISTp-AL). Women
were prescribed daily ferrous sulfate (200 mg) and folic acid
(0.4 mg) for the duration of their pregnancy and provided
with a long-lasting insecticide treated bed net (LLIN) at
enrollment.
At the initial ANC visit in all 4 countries and, in Ghana, at
subsequent ANC visits and at delivery, women were screened
with the First Response Malaria Rapid Diagnostic Combo Test.
This RDT detects both parasite lactate dehydrogenase (pLDH)
of P. falciparum, P. vivax, P. malariae and P. ovale, and Histi-
dine-Rich Protein 2 (HRP2) of P. falciparum; it was used
throughout the study according to the manufacturer’s instruc-
tions. Women who were RDT positive were treated with AL
(UNICEF, Copenhagen) twice daily for 3 days, with the ﬁrst
dose given under observation. At each ANC visit, a ﬁnger
prick blood sample was obtained for preparation of a blood
ﬁlm and ﬁlter paper blood spots for molecular analyses; blood
ﬁlms were examined later and did not affect a woman’s clini-
cal management. Women who attended an ANC outside a
scheduled visit with symptoms compatible with malaria were
screened with an RDT if clinic staff considered malaria to be
a possible cause of their symptoms, and those who tested pos-
itive were treated with AL. Hemoglobin (Hb) concentration was
determined at a woman’s last ANC attendance, scheduled to
occur between 36 and 40 weeks of gestation. Study women
were encouraged to deliver in hospital where placental biopsies
were obtained. Birth weight was recorded at delivery in women
who delivered in hospital and within 7 days of delivery in
women who delivered at home.
Three co-primary outcomes deﬁned for the main trial were
used to explore the possible consequences of infections missed
by a RDT: (a) low birth weight, deﬁned as measured birth weight
of a live, singleton birth of <2500 g recorded within 7 days of
delivery, (b) Hb concentration measured at the last ANC visit,
and (c) active malaria infection of the placenta deﬁned as the
presence of malaria parasites on histological examination of
the placenta, with or without malaria pigment or inﬂammatory
cells. Measured birth weight was also investigated as a key sec-
ondary outcome.
Laboratory Methods
Hemoglobin concentrations were measured using an Hb 301
Hemocue analyser (HemoCue, Anglom, Sweden). Thick blood
smears were examined by 2 microscopists and discrepancies
resolved by a third microscopist using a standardized algorithm
[17]. Parasite density was estimated by counting the number of
parasites per white blood cell, assuming a white cell count of
8000 per µL. One hundred thick blood ﬁlm ﬁelds were read be-
fore a slide was considered negative. Nested polymerase chain
reaction (PCR) assays were conducted at the MRC Unit, The
Gambia. Following DNA extraction from ﬁlter paper samples,
a ﬁrst stage PCR assay was carried out using the primers
rPLU5 + rPLU6, which detect P. falciparum, P. vivax, P. ovale,
and P. malariae. A second stage reaction on positive samples was
then conducted using the species-speciﬁc primers Plasmo-1 +
Plasmo-2, for detection of P. falciparum. A third stage assay
was conducted on samples that were genus speciﬁc but P. falcip-
arum negative using additional species speciﬁc primers (Sup-
plementary Methods). Quality control of the PCR assay at
Duke University, North Carolina, showed that its limit of sen-
sitivity was approximately 10 parasites per microliter. Only
samples that were positive for P. falciparum are included in
this study. Examination of placental biopsies was conducted
as described in the Supplementary Methods.
Evaluation of RDT Performance
Stata version 13 (StataCorp, College Station, Texas) was used for
all analyses. A woman was considered positive for P. falciparum
infection if either the blood smear or PCR assay indicated P. fal-
ciparum and negative if both tests were negative. Geometric
mean parasite density was determined at baseline based on mi-
croscopy. The sensitivity and speciﬁcity of the RDT against the
combined PCR/blood smear gold standard was calculated for
each ANC contact at which ISTp-AL was administered and at
delivery. The diagnostic ability of RDT, microscopy, PCR, and
PCR combined with microscopy to detect active malaria infec-
tion of the placenta was investigated. Infection status at base-
line and at subsequent ANC contacts was deﬁned as (1) not
infected, (2) infected and RDT positive, or (3) infected and
RDT negative. The association of infection status with maternal
characteristics including gravidity, age, gestational age at en-
rollment, educational level, season of enrollment and socio-
economic status (calculated using principal components
analysis of durable assets as described previously [17]) was
then explored. Risk factors for P. falciparum infections not de-
tected by an RDT were investigated using univariable and mul-
tivariable logistic regression comparing detected vs undetected
infections. Finally, the association between malaria infections
missed by RDT at routine ANC visits and the 3 primary
study outcomes (low birth weight, Hb at the ﬁnal ANC contact,
and placental malaria infection) plus mean birth weight was ex-
plored using multivariable logistic regression (for binary out-
comes) and linear regression (for continuous outcomes).
Ethics
The study and subsequent study amendments were approved by
the London School of Hygiene and Tropical Medicine Ethics
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Committee and by the ethics committees of all the partner Af-
rican institutions which are listed in the Supplement. The trial
was registered with ClinicalTrials.gov (NCT01084213) and the
Pan African Clinical trials Registry (PACT201202000272122).
Written, informed consent was obtained from all eligible
women before enrollment.
RESULTS
The prevalence of malaria at enrollment, detected by microsco-
py or PCR, was highest in Burkina Faso (70.0%), followed by
Ghana (58.6%), Mali (35.9%), and The Gambia (15.1%). Primi-
gravidae were more likely than secundigravidae to be infected at
ﬁrst ANC visit at all centers.
RDT Positivity in Pregnant Women at Enrollment in Burkina Faso,
Ghana, Mali, and The Gambia
At enrollment, the overall sensitivity of the RDT in detecting ma-
laria infection was 87.4% (95% conﬁdence interval [CI], 85.3%,
89.4%). Sensitivity was high in Burkina Faso (90.9% [95% CI,
87.5, 93.6]), Ghana (88.8% [95% CI, 85.0%, 91.9%]), and Mali
(86.8% [95% CI, 81.2, 91.3]) but lower in The Gambia (59.3%
[95% CI, 47.8, 70.1]) where geometric mean parasite density
among blood slide positive women was lower than at the other
centers (Table 1). Speciﬁcity was high at all centers (Table 1 and
Supplementary Figure 1). More than half of all infections detected
by an RDT at ANC contacts throughout pregnancy were detected
at enrollment: 55.6% overall, and 54.1%, 53.6%, 61.5%, and 60.2%
in Burkina Faso, Ghana, Mali, and The Gambia, respectively.
RDT Positivity During the Course of Pregnancy in Ghana
The prevalence of P. falciparum infection in Ghanaian pregnant
women was highest at enrollment and remained high through-
out pregnancy (Table 2). Supplementary Figure 2 shows the
overlap in the diagnosis of P. falciparum malaria by RDT,
PCR, and blood smear microscopy at any routine ANC contact
at which Ghanaian women were screened.
The sensitivity of the RDT against the combined measure of
PCR and/or blood smear positivity at ﬁrst ANC visit was 88.8%
(95% CI, 85.0%, 91.9%), 83.7% (95% CI, 76.2%, 89.6%) at sec-
ond ANC visit, 77.4% (95% CI, 67.0%, 85.8%) at third ANC vis-
its, and 48.6% (95% CI, 31.4%, 66.0%) at delivery (Table 2 and
Supplementary Figure 3). Speciﬁcity was generally high, >80%
on all occasions in all gravidities but slightly higher in secundi-
gravidae than in primigravidae (Table 2). During the course of
pregnancy, 709 positive RDT tests were obtained, 380 of which
(53.6%) were obtained at enrollment. Screening with an RDT
at enrollment detected 339 of the 639 P. falciparum infections
detected by microscopy or PCR during the course of pregnancy
(53.1% [95% CI, 49.1%, 57.0%]). One or more infections were
recorded subsequently in 172 of the 380 women (45.2%) who
were positive at enrollment by RDT compared to 101 (36.2%)
in the 272 women who had a negative RDT test at enrollment.
There were 212 positive RDTs at subsequent ANC contacts
among the 380 women who were RDT positive at the ﬁrst ANC
visit, compared to 117 positive RDTs among the 272 women
RDT negative at baseline giving an incidence rate ratio of 1.30
(95% CI, 1.03, 1.63), P = .024.
The sensitivity of the RDT in detection of active malaria
infection of the placenta was 73.1% (95% CI, 63.8%, 81.2%)
overall and 82.1% (95% CI, 70.8%, 90.4%) in primigravidae
(Table 3). The sensitivity of PCR in detection of placental ma-
laria was slightly lower than that of the RDT: 67.0% (95% CI,
56.2%, 76.7%) overall and 74.1% (60.3%, 85.0%) in primigravi-
dae. PCR combined with blood smear had a similar sensitivity
to RDT: 73.8% (95% CI, 64.2%, 82.0%) overall and 80.0% (95%
Table 1. Sensitivity and Specificity of an Rapid Diagnostic Test in Detecting Malaria Infection, as Defined by Positive Microscopy or a Positive
Polymerase Chain Reaction Assay in Peripheral Blood, at Initial Antenatal Clinic Visits in Pregnant Women in Four West African Countries
Gravidity
PCR or Blood Slide /RDT
RDT Sensitivity %
(95% CI)
RDT Specificity %
(95% CI)
Number Positives
With Density Result
Geometric Mean Density
by Microscopya,
Parasites per µL (95% CI)+/+ +/− −/+ −/−
Burkina Faso All 348 35 10 160 90.9 (87.5, 93.6) 94.1 (89.4, 97.1) 591 1054.5 (951.5, 1168.7)
Primigravidae 208 14 2 57 93.7 (89.6, 96.5) 96.6 (88.3, 99.6) 360 1372.3 (1213.1, 1552.3)
Secundigravidae 137 21 8 103 86.7 (80.4, 91.6) 92.8 (86.3, 96.8) 221 683.2 (576.5, 809.7)
Ghana All 308 39 23 222 88.8 (85.0, 91.9) 90.6 (86.2, 94.0) 618 1950.0 (1760.8, 2159.6)
Primigravidae 193 10 15 99 95.1 (91.1, 97.6) 86.8 (79.2, 92.4) 402 2403.9 (2127.7, 2715.9)
Secundigravidae 113 29 8 122 79.6 (72.0, 85.9) 93.8 (88.2, 97.3) 214 1314.8 (1104.9, 1564.6)
Mali All 165 25 15 283 86.8 (81.2, 91.3) 95.0 (91.8, 97.2) 275 1343.5 (1131.4, 1595.3)
Primigravidae 118 10 11 168 92.2 (86.1, 96.2) 93.9 (89.3, 96.9) 201 1431.5 (1169.6, 1752.1)
Secundigravidae 47 15 4 115 75.8 (63.3, 85.8) 96.6 (91.6, 99.1) 74 1130.6 (812.2, 1573.8)
The Gambia All 48 33 5 463 59.3 (47.8, 70.1) 98.9 (97.5, 99.7) 93 398.4 (307.0, 517.2)
Primigravidae 35 20 1 246 63.6 (49.6, 76.2) 99.6 (97.8, 100.0) 63 399.2 (291.3, 547.0)
Secundigravidae 13 13 4 217 50.0 (29.9, 70.1) 98.2 (95.4, 99.5) 30 397.0 (242.5, 649.9)
A true positive has been defined as a positive PCR or blood slide result, a true negative as a PCR and blood slide negative result.
Abbreviations: CI, confidence interval; PCR, polymerase chain reaction; RDT, rapid diagnostic test.
a Geometric mean parasite density is based on individuals who tested positive by blood slide: ie, this it does not include low density infections that were missed by microscopic examination.
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CI, 68.2%, 88.9%) in primigravidae. In sum, 15 and 14 of the 29
placental infections missed by RDT and by PCR, respectively,
were recorded as acute infections (ie, parasite present with no
malaria pigment, which may indicate a recent infection), sug-
gesting that around half of these “missed” infections may
have been acquired after the diagnostic test was done.
Risk Factors for RDT Positive and RDT Negative Malaria Infections
Infection at ﬁrst ANC attendance was more likely among primi-
gravidae, young women, mothers with a basic education, mothers
enrolled in the late wet or early dry season, and mothers of low
socioeconomic status (Supplementary Table 2). In crude analysis,
gravidity, older age, and educational status were associated with
Table 2. Prevalence of Malaria Infection in Peripheral Blood at Different Time Points in Pregnant Ghanaian Women and Sensitivity and Specificity of an
Rapid Diagnostic Test at These Time Points
Gravidity
Number
Tested
Number
Positivea
% Positive by
PCR or Blood
Slide (95% CI)
PCR or Microscopy/RDT
Result
RDT Sensitivity % RDT Specificity %+/+ +/− −/+ −/−
Peripheral blood
First ANC Visit All 592 347 58.6 (54.6, 62.5) 308 39 23 222 88.8 (85.0, 91.9) 90.6 (86.2, 94.0)
Primigravidae 317 203 64.0 (58.6, 69.2) 193 10 15 99 95.1 (91.1, 97.6) 86.8 (79.2, 92.4)
Secundigravidae 272 142 52.2 (46.2, 58.1) 113 29 8 122 79.6 (72.0, 85.9) 93.8 (88.2, 97.3)
Second ANC Visit All 491 129 26.3 (22.6, 30.4) 108 21 39 323 83.7 (76.2, 89.6) 89.2 (85.6, 92.2)
Primigravidae 265 74 27.9 (22.8, 33.7) 66 8 28 163 89.2 (79.8, 95.2) 85.3 (79.5, 90.0)
Secundigravidae 224 55 24.6 (19.3, 30.7) 42 13 10 159 76.4 (63.0, 86.8) 94.1 (89.4, 97.1)
Third ANC Visit All 384 84 21.9 (18.0, 26.3) 65 19 43 257 77.4 (67.0, 85.8) 85.7 (81.2, 89.4)
Primigravidae 201 51 25.4 (19.8, 31.9) 40 11 27 123 78.4 (64.7, 88.7) 82.0 (74.9, 87.8)
Secundigravidae 182 32 17.6 (12.7, 23.9) 24 8 16 134 75.0 (56.6, 88.5) 89.3 (83.3, 93.8)
Delivery All 158 35 22.2 (16.3, 29.4) 17 18 17 106 48.6 (31.4, 66.0) 86.2 (78.8, 91.7)
Primigravidae 80 20 25.0 (16.6, 35.9) 11 9 11 49 55.0 (31.5, 76.9) 81.7 (69.6, 90.5)
Secundigravidae 78 15 19.2 (11.8, 29.7) 6 9 6 57 40.0 (16.3, 67.7) 90.5 (80.4, 96.4)
The number of women with missing gravidity status was first visit, 3; second visit, 2; third visit, 1; delivery, 0.
Abbreviations: ANC, antenatal clinic; CI, confidence interval; PCR, polymerase chain reaction; RDT, rapid diagnostic test.
a Positivity in peripheral blood is defined as either a positive PCR result or a positive blood slide.
Table 3. The Prevalence of Placental Malaria, and the Sensitivity and Specificity of an Rapid Diagnostic Test, Polymerase Chain Reaction (PCR) or PCR/
Microscopy Undertaken at any Antenatal Contact in Predicting Active Malaria Infection of the Placenta Detected by Histology in Ghanaian Women
Placental Malariaa
Gravidity Number Tested Number Positive Percent Positive by Histology
All Women 425 122 28.7 (24.6, 33.2)
Primigravidae 243 76 31.3 (25.7, 37.4)
Secundigravidae 181 46 25.4 (19.6, 32.3)
Histology/Diagnostic
Sensitivity % (95% CI) Specificity % (95% CI)+/+ +/− −/+ −/−
Diagnostic
RDT positive at any ANC contact All 79 29 196 67 73.1 (63.8, 81.2) 25.5 (20.3, 31.2)
Primigravidae 55 12 117 28 82.1 (70.8, 90.4) 19.3 (13.2, 26.7)
Secundigravidae 24 17 78 39 58.5 (42.1, 73.7) 33.3 (24.9, 42.6)
Microscopy positive at any ANC contact All 65 43 149 112 60.2 (50.3, 69.5) 42.9 (36.8, 49.2)
Primigravidae 46 21 89 54 68.7 (56.2, 79.4) 37.8 (29.8, 46.2)
Secundigravidae 19 22 60 57 46.3 (30.7, 62.6) 48.7 (39.4, 58.1)
PCR positive at any ANC contact All 59 29 152 79 67.0 (56.2, 76.7) 34.2 (28.1, 40.7)
Primigravidae 40 14 85 37 74.1 (60.3, 85.0) 30.3 (22.3, 39.3)
Secundigravidae 19 15 67 41 55.9 (37.9, 72.8) 38.0 (28.8, 47.8)
PCR or blood slide positive at any ANC Contact All 76 27 190 64 73.8 (64.2, 82.0) 25.2 (20.0, 31.0)
Primigravidae 52 13 109 30 80.0 (68.2, 88.9) 21.6 (15.1, 29.4)
Secundigravidae 24 14 81 33 63.2 (46.0, 78.2) 28.9 (20.8, 38.2)
1 woman with a placental malaria result had missing data on gravidity.
Abbreviations: ANC, antenatal clinic; CI, confidence interval; PCR, polymerase chain reaction; RDT, rapid diagnostic test.
a Positivity for placental malaria is defined as the detection of malaria parasites in the placenta on histological examination.
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infection missed by RDT (Table 4), but after adjusting for co-
variates, only gravidity remained weakly associated, with missed
infections being more frequent in secundigravidae than primigra-
vidae OR 1.85 (1.00, 3.43) (P = .050).
RDT Positive and RDT Negative Malaria Infections and the Outcome of
Pregnancy
Low birth weight was not associated with either RDT negative/
PCR or microscopy positive peripheral blood infections or
with RDT positive/PCR or microscopy positive infections
[aOR 0.82 (95% CI, .37, 1.81) and aOR 0.84 (95% CI, .47,
1.50), respectively] (Table 5). There was also no association be-
tween infection status and measured birth weight. Infection sta-
tus was not associated with Hb concentration at the ﬁnal ANC
contact [adjusted mean difference between uninfected women
and those who were infected but RDT positive and those who
were infected but RDT negative −0.08 g/dL (95% CI, −.60, .44)
and −0.25 g/dL (95% CI, −.76, .25), respectively]. Finally, there
was no evidence that either infections detected by RDT or
infections missed by RDT were associated with placental malar-
ia infection [aOR 0.93 (95% CI, .51, 1.68) and 1.02 (95% CI, .44,
2.34), respectively].
DISCUSSION
Intermittent screening and treatment provides a possible ap-
proach to the management of malaria in pregnancy in certain
epidemiological situations. There are, however, concerns that
infections present at too low a density to be detected with an
RDT could have an adverse effect on the outcome of pregnancy.
In Ghana, the sensitivity of a PLDH/HRP2 combination RDT
in detection of malaria infection of peripheral blood was high
throughout pregnancy until delivery when there was a substan-
tial drop. The reason for the lower sensitivity of the RDT at de-
livery is likely to be the fact that the proportion of low-density
infections was higher at this time than earlier in pregnancy be-
cause of treatment of RDT positive infections and possibly some
acquisition of immunity as the pregnancy progressed. Mean
Table 4. Risk Factors for an Rapid Diagnostic Test (RDT) Negative Malaria Infection, as Defined by a Positive Blood Film or RDT Test, in Pregnant Ghanaian
Women at Any Stage During Pregnancy
Infecteda, RDT+ve Infecteda, RDT-
Crude OR P Value Adjusted OR P ValueNo. % No. %
Gravidity
1 239 88.8 30 11.2 [reference] . . . [reference] . . .
2 148 76.7 45 23.3 2.42 (1.46, 4.02) .001 1.85 (1.00, 3.43) .050
Gestational age at enrollment
<20 wks 176 86.7 27 13.3 [reference] . . . [reference] . . .
20–24 wks 176 81.5 40 18.5 1.48 (0.87, 2.52) .147 1.62 (0.92, 2.85) .094
25–30 wks 37 82.2 8 17.8 1.41 (0.59, 3.35) .437 1.62 (0.65, 4.04) .300
Age group
under 18 35 89.7 4 10.3 [reference] . . . [reference] . . .
18–20 180 89.1 22 10.9 1.07 (0.35, 3.30) .907 0.95 (0.30, 3.02) .934
21–24 108 76.6 33 23.4 2.67 (0.89, 8.08) .081 1.80 (0.54, 6.01) .339
25 y + 66 80.5 16 19.5 2.12 (0.66, 6.83) .208 1.37 (0.37, 5.05) .639
Education
1-None 76 75.2 25 24.8 [reference] . . . [reference] . . .
2-Basic 264 87.1 39 12.9 0.45 (0.26, 0.79) .005 0.63 (0.34, 1.17) .139
3-Secondary 40 80 10 20 0.76 (0.33, 1.74) .516 0.89 (0.36, 2.25) .812
4-Tertiary 9 90 1 10 0.34 (0.04, 2.80) .314 0.42 (0.05, 3.89) .443
Season enrolled
early wet 139 85.3 24 14.7 [reference] . . . [reference] . . .
late wet 95 81.9 21 18.1 1.28 (0.67, 2.43) .450 1.18 (0.60, 2.33) .630
early dry 68 82.9 14 17.1 1.19 (0.58, 2.45) .632 1.12 (0.53, 2.39) .769
late dry 87 84.5 16 15.5 1.07 (0.54, 2.12) .857 1.07 (0.52, 2.23) .851
SES
1-wealthiest 67 83.8 13 16.3 [reference] . . . [reference] . . .
2-wealthy 71 86.6 11 13.4 0.80 (0.34, 1.91) .612 0.86 (0.35, 2.11) .738
3-medium 88 88.9 11 11.1 0.64 (0.27, 1.53) .318 0.76 (0.31, 1.90) .558
4-poor 74 77.1 22 22.9 1.53 (0.72, 3.28) .272 1.88 (0.83, 4.28) .132
5-poorest 88 83 18 17 1.05 (0.48, 2.30) .895 1.08 (0.46, 2.52) .868
P-values from Wald test.
Abbreviations: OR, odds ratio; PCR, polymerase chain reaction; RDT, rapid diagnostic test; SES, socio-economic status.
a Infected = a positive PCR test or blood film.
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parasite densities were measured at different time points during
pregnancy in women who had a positive blood ﬁlm and did not
show a signiﬁcant decrease at delivery (data not shown), but this
ﬁnding does not reﬂect the fact that at the time of delivery, a
high proportion of infections may have been present at a density
that was too low to be detected by microscopy but which were
detected by PCR. The sensitivity of the RDT used in our study
was high in 3 countries, but our study was restricted to analysis
of P. falciparum infections in primigravidae and secundigravi-
dae. Different results might have been obtained in multigravi-
dae, in whom parasite densities are generally lower than in
primigravidae, and in areas where P. vivax is prevalent, as
RDTs are generally less sensitive in detecting P. vivax than
P. falciparum infections.
The sensitivity of the RDT in detection of active malaria in-
fection of the placenta in our study was 73.1% overall and 82.1%
in primigravidae (Table 3). Previous studies of the sensitivity
of RDTs in detecting “pregnancy malaria,” reviewed by Fried
et al [18], have shown variable results, in part because different
end-points have been used including peripheral blood smear,
placental blood smear, placental histology or a combination of
these end-points. As expected, HRP2 tests have generally shown
higher sensitivity than pLDH assays because of persistence of
the HRP 2 antigen and because this antigen can access the cir-
culation from sequestered parasites [19]. In 2 previous studies in
which an HRP2 test on peripheral blood was used to detect pla-
cental malaria as deﬁned by histology, the RDT had a sensitivity
of 78% and 81% [20, 21], percentages similar to the 73% found
in our study. PCR assays have, in general, shown a higher sen-
sitivity in detection of placental malaria than an RDT [18], but
in our study the sensitivity of PCR on peripheral blood was
slightly lower than that of the RDT, despite the ability of the
PCR assay used in our study to detect very low density infec-
tions (approximately 10 parasites per µL). The reason for the
generally good performance of the RDT used in this study
in comparison with PCR was not that the PCR had a low
sensitivity.
We did not ﬁnd that RDT negative/PCR positive infections
were associated with any adverse effect on the outcome of preg-
nancy, perhaps contributing to the reason why ISTp-AL was
found to be noninferior to IPTp-SP in our trial. However,
only a small number of Ghanaian women (75) had a RDT neg-
ative/PCR positive infection, so the study was not powered to
detect a small effect. Many previous studies have shown an as-
sociation between a positive blood ﬁlm, RDT or PCR assay and
1 or more adverse outcomes of pregnancy. Whether infections
that are PCR positive but RDT or microscopy negative are as-
sociated with a poor outcome of pregnancy is less certain and is
an important issue if ISTp is to be considered for implementa-
tion in some epidemiological situations. Some studies have
shown an association between submicroscopic infections and
maternal anemia [22–24] or low birth weight [25, 26], but
other studies have not shown any association between PCR pos-
itive but RDT or microscopy negative infections and an adverse
Table 5. Associations Between Rapid Diagnostic Test (RDT) + ve and RDT –ve Malaria Infections, as Defined by Positive Microscopy or Polymerase Chain
Reaction, and Various Outcome of Pregnancy
Uninfecteda Infected, RDT+veb Infected, RDT−vec
No. % No. % No. %
No active placental malaria 64 70.3 154 71 36 73.5
Active placental malariad 27 29.7 63 29 13 26.5
Crude OR (95% CI), P-value [reference] 0.97 (.57, 1.66) 0.911 0.86 (.39, 1.86) 0.695
Adjusted ORe (95% CI), P-value [reference] 0.93 (.51, 1.68) 0.807 1.02 (.44, 2.34) 0.972
Normal birth weight 97 78.2 257 81.8 60 83.3
Low birth weight 27 21.8 57 18.2 12 16.7
Crude OR (95% CI), P-value [reference] 0.80 (.48, 1.33) 0.386 0.72 (.34, 1.53) 0.389
Adjusted OR (95% CI), P-value [reference] 0.84 (.47, 1.50) 0.552 0.82 (.37, 1.81) 0.621
Mean SD Mean SD Mean SD
Birth weight (kg) 2.77 0.50 2.73 0.49 2.80 0.38
Crude difference, grams (95% CI), P-value [reference] −37.2 (−136.6, 62.2) 0.463 28.3 (−110.6, 167.2) 0.689
Adjusted difference, grams (95% CI), P-value [reference] −18.2 (−124.0, 87.7) 0.736 19.1 (−122.3, 160.5) 0.791
Hb at final antenatal clinic visit 10.90 1.27 10.70 1.30 10.82 1.17
Crude difference, g/dL (95% CI), P-value [reference] −0.20 (−.58, .18) 0.296 −0.38 (−.78, .02) 0.062
Adjusted difference, g/dL (95% CI), P-value [reference] −0.08 (−.60, .44) 0.767 −0.25 (−.76, .25) 0.325
Abbreviations: ANC, antenatal clinic; CI, confidence interval; Hb, hemoglobin; OR, odds ratio; PCR, polymerase chain reaction; RDT, rapid diagnostic test; SD, standard deviation.
a Uninfected. This group of women were negative for malaria infection by PCR, RDT, and microscopy when ever tested at a routine ANC visit.
b Infected RDT +ve. This group of women had a malaria infection detected by PCR or by microscopy, which was also detected by RDT.
c Infected RDT −ve. This group of women had a malaria infection detected by PCR or by microscopy, which was not detected by RDT.
d Active malaria infection. This is defined as the detection of malaria parasites in the placenta on histological examination with or without the presence of pigment and/or inflammatory cells.
e Adjusted ORs/difference: multivariable model adjusting for gravidity, gestational age at enrollment, age, education level, socio-economic status, and season of delivery.
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outcome of pregnancy [27, 28] as in our study. The reasons for
this discrepancy is uncertain but it may reﬂect differences in the
characteristics of the study population, the number of subjects
studied, and the sensitivity of the RDT and PCR assays used.
It has been suggested that ISTp could be adopted in areas
where IPTp-SP is currently deployed but where the level of
transmission has fallen to such a low level that few pregnant
women are at risk. However, in such situations, the cost per
case of malaria prevented would be high. A possible, more cost
effective, approach could be to restrict screening to ﬁrst ANC
visits as, in this study, this approach detected over 50% of all
infections diagnosed in the pregnancy. Women who tested pos-
itive at enrollment were at increased risk of a further infection,
and so these women could be followed with further screening.
However, the lowest sensitivity of the RDT seen in this study
was at the site with the lowest transmission; it is not clear if
this is a causal association due to lower average parasite densi-
ties, but this is a possible explanation for this observation. It is
also unclear if sensitivity would decline further over the course
of pregnancy in lower transmission settings, and this needs to
be investigated. As the incidence of malaria falls in many previ-
ously highly endemic areas, new approaches to the control of
malaria in pregnancy need to be developed and evaluated.
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